RLMD Relmada Therapeutics Inc

         10.           CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
                       CERTAIN SHARES (SEE INSTRUCTIONS)          [_]


11.     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.82%*

12.     TYPE OF REPORTING PERSON
         (SEE INSTRUCTIONS)
        CO


1.      NAME OF REPORTING PERSONS

CUSIP No.:



75955J402







Item 3. If This Statement is filed pursuant to
        ??.240.13d-1(b) or 240.13d-2(b), or (c),
        check whether the person filing is a

                        N/A

Item 4. Ownership.

Provide the following information regarding
the aggregate number and percentage of the
class of securities of the issuer
identified in Item 1.

(a)     Amount beneficially owned:

     RTW Investments, LP ? 1,255,857 *
     RTW Master Fund, Ltd. ? 884,400 *
     Roderick Wong ? 1,255,857 *

(b)     Percent of class:
RTW Investments, LP ? 8.26%*
     RTW Master Fund, Ltd. ? 5.82%*
Roderick Wong ? 8.26%*


(c)             Number of shares as to which the person has:

(i)     Sole power to vote or to direct the vote

RTW Investments, LP ? 0
     RTW Master Fund, Ltd. ? 0
Roderick Wong ? 0

(ii)    Shared power to vote or to direct the vote

                      RTW Investments, LP ? 1,255,857 *
                                    RTW Master Fund, Ltd. ? 884,400 *
            Roderick Wong ? 1,255,857 *


(iii)   Sole power to dispose or to direct the disposition of

RTW Investments, LP ? 0
     RTW Master Fund, Ltd. ? 0
Roderick Wong ? 0

(iv)    Shared power to dispose or to direct the disposition of

                      RTW Investments, LP ? 1,255,857 *
            RTW Master Fund, Ltd. ? 884,400 *
            Roderick Wong ? 1,255,857 *


* The Common Stock (the "Shares"), of Relmada Therapeutics,
Inc. (the "Company") reported herein are held by RTW Master
Fund, Ltd. and one or more private funds (together the "Funds")
managed by RTW Investments, LP (the "Adviser").  The Adviser,
in its capacity as the investment manager of the Funds, has the
power to voteand the power to direct the disposition of all Shares
held by the Funds.  Accordingly, for the purposes of Reg. Section
240.13d-3, the Adviser may be deemed to beneficially own an
aggregate of 1,255,857 Shares, or 8.26% of the Company?s
15,198,109 Shares deemed issued and outstanding as of May 13,
2020. Roderick Wong is the Managing Partner of the Adviser.
This report shall not be deemed an admission that the
Adviser, the Funds or any other person is the beneficial owner
of the securities reported herein for purposes of Section 13 of the
Securities Exchange Act of 1934, as amended, or for any other
purpose.  Each of the reporting persons herein disclaims beneficial
ownership of the Shares reported herein except to the extent
of the reporting person?s pecuniary interest therein.








Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that
as of the date hereof the reporting person has ceased
to be the beneficial owner of more than five percent
of the class of securities, check the following  [   ].


N/A



Item 6. Ownership of More Than Five Percent on Behalf of Another
        Person.

If any other person is known to have the right to receive
or the power to direct the receipt of dividends from, or the
proceeds from the sale of, such securities, a statement to
that effect should be included in response to this item and,
if such interest relates to more than 5 percent of the class,
 such person should be identified.  A listing of the
shareholders of an investment company registered under the
Investment Company Act of 1940 or the beneficiaries of
employee benefit plan, pension fund or endowment
fund is not required.

N/A



Item 7. Identification and Classification of the Subsidiary
        Which Acquired the Security Being Reported on
        by the Parent Holding Company or Control
        Person.

If a parent holding company or control person has
filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G),
so indicate under Item 3(g) and attach an exhibit stating
the identity and the Item 3 classification of the relevant
subsidiary.  If a parent holding company or control person
has filed this schedule pursuant to Rule 13d-1(c) or Rule
13d-1(d), attach an exhibit stating the identification of the
relevant subsidiary.

N/A



Item 8. Identification and Classification of Members of the Group.

If a group has filed this schedule pursuant to ?240.13d-1(b)(1)(ii)(J),
so indicate under Item 3(j) and attach an exhibit stating the identity
and Item 3 classification of each member of the group. If a group has
filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach
an exhibit stating the identity of each member of the group.

N/A



Item 9. Notice of Dissolution of Group.

Notice of dissolution of a group may be furnished as an
exhibit stating the date of the dissolution and that all further
filings with respect to transactions in the security reported on
will be filed, if required, by members of the group, in their
individual capacity.
See Item 5.

N/A



Item 10.   Certification.

By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.




SIGNATURE

      After reasonable inquiry and to the best of my knowledge and
      belief, I certify that the information set forth in this statement
      is true, complete and correct.



        Dated: June 10, 2020
        RTW Investments, LP

By: /s/ Roderick Wong
Roderick Wong, Managing Partner


        RTW Master Fund, Ltd.

By: /s/ Roderick Wong
Roderick Wong, Director


        Roderick Wong

By: /s/ Roderick Wong
Roderick Wong, Individually



The original statement shall be signed by each person
on whose behalf the statement is filed or his authorized
representative.  If the statement is signed on behalf of
a person by his authorized representative other than an
executive officer or general partner of the filing person,
evidence of the representative's authority to sign on
behalf of such person shall be filed with the statement,
provided, however, that a power of attorney for this
purpose which is already on file with the Commission may
be incorporated by reference.  The name and any title of
each person who signs the statement shall be typed or
printed beneath his signature.

Note.  Schedules filed in paper format shall include a
signed original and five copies of the schedule,
including all exhibits.  See s.240.13d-7 for
other parties for whom copies are to be sent.

Attention.  Intentional misstatements or omissions
of fact constitute Federal criminal violations
(see 18 U.S.C. 1001).














      Exhibit 1
Joint Filing Statement
Pursuant to Rule 13d-1(k)(1)


The undersigned hereby consent and agree to the
joint filing of Schedule 13G under the Securities
Exchange Act of 1934, as amended, with respect
to the Common Stock of Relmada Therapeutics,
Inc. beneficially owned by them, together with
any or all amendments thereto, when and if
appropriate. The parties hereto further consent
and agree to file this Joint Filing Statement
pursuant to Rule13d-1(k)(1)(iii) as an exhibit
to Schedule 13G, thereby incorporating the
same into such Schedule13G.

This Joint Filing Statement may be terminated
by any of the undersigned upon written notice
or such lesser period of notice as the undersigned
may mutually agree.

        Dated: June 10, 2020
        RTW Investments, LP

By: /s/ Roderick Wong
Roderick Wong, Managing Partner

        RTW Master Fund, Ltd.

By: /s/ Roderick Wong
Roderick Wong, Director


        Roderick Wong

By: /s/ Roderick Wong
Roderick Wong, Individually